GSK plc

GSK · LSE · Healthcare / Drug Manufacturers - General

1,911.50GBX+10.50 (+0.55%)

Price History

Full chart

Market Stats

Previous Close1,901.00

Open1,897.50

Day Range1,892.00 – 1,921.00

52-Week Range1,537.28 – 2,224.17

Volume3.10M

Market Cap71.31B

P/E (TTM)15.08

Forward P/E9.72

EPS1.18

Dividend Yield3.82%

Beta0.29

50-Day Avg1,879.10

200-Day Avg1,957.38

About

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - General
CEOMs. Julie Belita Brown A.C.A.
Employees66.84K
Headquarters79 New Oxford Street, London, United Kingdom, WC1A 1DG, UK
Websitehttps://www.gsk.com

Leadership

Ms. Julie Belita Brown A.C.A.CFO & Executive Director · b. 1962
Ms. Emma Natasha WalmsleyExecutive Officer · b. 1969

Financials

Income Statement

Currency: GBP	1987-06-30	1988-06-30	1989-06-30	1990-06-30	1991-06-30	1992-06-30	1993-06-30	1994-06-30	1995-06-30	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	1987-06-30	1988-06-30	1989-06-30	1990-06-30	1991-06-30	1992-06-30	1993-06-30	1994-06-30	1995-06-30	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	1.74B	2.06B	2.57B	3.18B	3.40B	4.10B	4.93B	5.66B	6.48B	10.49B	8.34B	7.98B	7.98B	8.49B	18.08B	20.53B	21.21B	21.44B	19.99B	21.66B	23.23B	22.72B	24.35B	28.37B	28.39B	27.39B	26.43B	26.50B	23.01B	23.92B	27.89B	30.19B	30.82B	33.75B	34.10B	24.70B	29.32B	30.33B	31.38B	32.67B
Growth (%)	-	+18.27%	+24.82%	+23.70%	+6.86%	+20.58%	+20.36%	+14.73%	+14.57%	+61.88%	-20.49%	-4.33%	+0.04%	+6.35%	+112.94%	+13.58%	+3.30%	+1.08%	-6.79%	+8.38%	+7.23%	-2.19%	+7.20%	+16.49%	+0.08%	-3.54%	-3.49%	+0.28%	-13.20%	+3.99%	+16.58%	+8.24%	+2.10%	+9.52%	+1.02%	-27.58%	+18.74%	+3.42%	+3.46%	+4.11%
Cost of Revenue	-	-	-	-	-	-	-	-	904.11M	-	-	-	1.54B	4.33B	3.96B	4.44B	4.61B	4.54B	4.36B	4.76B	5.01B	5.40B	6.05B	7.18B	7.72B	7.87B	7.79B	8.20B	7.45B	8.92B	9.45B	10.10B	9.90B	10.87B	10.98B	8.35B	9.86B	9.08B	9.48B	8.97B
Gross Profit	1.74B	2.06B	2.57B	3.18B	3.40B	4.10B	4.93B	5.66B	5.58B	10.49B	8.34B	7.98B	6.44B	4.16B	14.12B	16.09B	16.60B	16.90B	15.63B	16.90B	18.21B	17.32B	18.30B	21.19B	20.68B	19.52B	18.64B	18.31B	15.56B	15.01B	18.44B	20.09B	20.93B	22.89B	23.12B	16.34B	19.46B	21.25B	21.90B	23.70B
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	86.05%	100.00%	100.00%	100.00%	80.65%	48.95%	78.09%	78.38%	78.27%	78.81%	78.18%	78.01%	78.43%	76.23%	75.14%	74.70%	72.82%	71.28%	70.54%	69.07%	67.63%	62.73%	66.11%	66.54%	67.89%	67.80%	67.81%	66.18%	66.37%	70.07%	69.80%	72.54%
Operating Expense	984.00M	1.21B	1.54B	1.95B	2.04B	2.81B	3.40B	3.84B	4.12B	8.11B	5.21B	5.16B	3.75B	1.53B	9.39B	9.99B	11.05B	10.52B	10.11B	10.39B	10.71B	9.86B	10.58B	12.75B	15.70B	11.90B	12.15B	11.11B	10.66B	10.55B	11.61B	12.11B	12.93B	15.10B	14.94B	10.94B	12.78B	14.26B	16.24B	16.53B
Operating Income	757.00M	853.00M	1.03B	1.23B	1.36B	1.29B	1.52B	1.82B	1.45B	2.38B	3.13B	2.82B	2.68B	2.63B	4.73B	6.10B	5.55B	6.38B	5.52B	6.51B	7.50B	7.46B	7.72B	8.44B	4.98B	7.62B	6.49B	7.20B	4.90B	4.46B	6.83B	7.97B	8.00B	7.78B	8.18B	5.41B	6.68B	6.99B	5.66B	7.17B
Operating Margin	43.48%	41.43%	40.16%	38.57%	39.98%	31.42%	30.93%	32.13%	22.43%	22.71%	37.55%	35.36%	33.61%	30.92%	26.16%	29.72%	26.17%	29.74%	27.62%	30.06%	32.30%	32.82%	31.69%	29.76%	17.54%	27.82%	24.56%	27.15%	21.29%	18.65%	24.49%	26.42%	25.95%	23.06%	24.00%	21.89%	22.79%	23.06%	18.05%	21.95%
EBITDA	812.00M	926.00M	1.13B	1.35B	1.51B	1.68B	1.96B	2.16B	1.78B	3.26B	3.65B	3.29B	3.23B	3.21B	5.80B	6.92B	6.54B	7.24B	6.92B	8.04B	9.05B	8.74B	8.51B	10.18B	5.52B	10.05B	8.76B	8.74B	5.10B	12.81B	4.39B	6.13B	7.33B	9.38B	10.16B	6.45B	8.63B	9.14B	6.67B	11.88B
EBITDA Margin	46.64%	44.97%	43.77%	42.40%	44.42%	41.04%	39.68%	38.21%	27.53%	31.05%	43.76%	41.18%	40.47%	37.80%	32.08%	33.68%	30.81%	33.78%	34.64%	37.10%	38.97%	38.46%	34.93%	35.88%	19.45%	36.71%	33.15%	32.99%	22.17%	53.55%	15.76%	20.31%	23.79%	27.78%	29.80%	26.13%	29.43%	30.13%	21.27%	36.38%
Net Income	510.00M	581.00M	688.00M	807.00M	881.00M	1.03B	1.21B	1.30B	1.04B	1.46B	2.00B	1.85B	1.84B	1.81B	4.16B	3.10B	3.94B	4.49B	3.91B	4.69B	5.39B	5.21B	4.60B	5.53B	1.63B	5.26B	4.50B	5.44B	2.76B	8.42B	912.00M	1.53B	3.62B	4.64B	5.75B	4.38B	14.96B	4.93B	2.58B	5.72B
Net Income Margin	29.29%	28.22%	26.77%	25.39%	25.93%	25.22%	24.48%	22.97%	16.04%	13.90%	23.94%	23.18%	23.00%	21.33%	23.02%	15.10%	18.55%	20.94%	19.55%	21.65%	23.20%	22.95%	18.90%	19.50%	5.76%	19.21%	17.02%	20.51%	11.98%	35.20%	3.27%	5.08%	11.75%	13.76%	16.86%	17.76%	51.00%	16.25%	8.21%	17.50%
R&D	149.00M	230.00M	323.00M	420.00M	475.00M	595.00M	739.00M	858.00M	-	1.54B	1.16B	1.15B	1.16B	1.27B	2.53B	2.56B	2.90B	2.79B	2.90B	3.14B	3.46B	3.26B	3.58B	3.97B	4.30B	3.69B	3.49B	3.44B	3.33B	3.42B	3.48B	3.87B	3.66B	4.25B	4.48B	4.39B	4.84B	5.25B	5.50B	7.51B
R&D as % of Total Revenue	8.56%	11.17%	12.57%	13.21%	13.98%	14.53%	14.99%	15.17%	-	14.68%	13.92%	14.39%	14.57%	14.95%	13.97%	12.47%	13.67%	13.02%	14.53%	14.48%	14.88%	14.33%	14.72%	14.01%	15.16%	13.46%	13.19%	12.96%	14.50%	14.30%	12.48%	12.80%	11.87%	12.58%	13.14%	17.76%	16.49%	17.29%	17.52%	22.98%
Interest Expense	11.00M	21.00M	26.00M	44.00M	75.00M	63.00M	56.00M	44.00M	0	337.00M	276.00M	227.00M	202.00M	206.00M	317.00M	1.15B	141.00M	161.00M	345.00M	452.00M	350.00M	313.00M	664.00M	790.00M	767.00M	718.00M	745.00M	726.00M	679.00M	669.00M	686.00M	698.00M	707.00M	895.00M	876.00M	765.00M	852.00M	775.00M	644.00M	701.00M
Interest Expense % of Total Revenue	0.63%	1.02%	1.01%	1.38%	2.21%	1.54%	1.14%	0.78%	0.00%	3.21%	3.31%	2.84%	2.53%	2.43%	1.75%	5.59%	0.66%	0.75%	1.73%	2.09%	1.51%	1.38%	2.73%	2.78%	2.70%	2.62%	2.82%	2.74%	2.95%	2.80%	2.46%	2.31%	2.29%	2.65%	2.57%	3.10%	2.91%	2.56%	2.05%	2.15%

Balance Sheet

Currency: GBP	1987-06-30	1988-06-30	1989-06-30	1990-06-30	1991-06-30	1992-06-30	1993-06-30	1994-06-30	1995-06-30	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	1987-06-30	1988-06-30	1989-06-30	1990-06-30	1991-06-30	1992-06-30	1993-06-30	1994-06-30	1995-06-30	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.36B	2.87B	3.47B	4.49B	5.74B	5.68B	7.46B	7.89B	8.10B	8.54B	8.31B	8.44B	9.35B	10.43B	21.59B	21.97B	22.33B	23.94B	22.64B	27.19B	25.54B	31.03B	39.39B	42.86B	42.23B	41.08B	41.48B	42.09B	40.65B	53.45B	59.08B	56.38B	58.07B	79.69B	80.43B	79.10B	60.15B	59.01B	59.46B	61.12B
Total Liabilities	894.00M	1.06B	1.16B	1.69B	2.46B	2.04B	2.80B	2.74B	7.53B	8.32B	7.05B	6.55B	6.58B	7.23B	12.63B	13.57B	14.94B	15.49B	16.49B	19.62B	15.90B	21.11B	31.07B	32.12B	32.48B	32.25B	34.74B	34.27B	35.72B	44.57B	54.12B	52.89B	54.39B	61.34B	59.62B	57.76B	50.05B	46.21B	46.38B	45.16B
Total Equity	1.45B	1.78B	2.29B	2.73B	3.21B	3.57B	4.55B	5.03B	410.48M	91.00M	1.23B	1.84B	2.70B	3.14B	7.71B	7.53B	6.58B	7.71B	5.88B	7.31B	9.38B	9.61B	7.93B	10.01B	8.89B	8.03B	5.80B	7.00B	4.26B	5.11B	1.12B	-68.00M	3.78B	11.40B	14.59B	15.05B	10.60B	13.35B	13.67B	16.38B
Cash	23.00M	40.00M	575.00M	266.00M	34.00M	24.00M	63.00M	55.00M	75.10M	233.00M	261.00M	215.00M	240.00M	217.00M	1.28B	717.82M	1.05B	960.96M	2.47B	4.21B	2.00B	3.38B	5.62B	6.54B	6.06B	5.71B	4.18B	5.53B	4.34B	5.83B	4.90B	3.83B	3.87B	4.51B	6.09B	4.07B	3.52B	2.75B	3.69B	3.15B
Total Debt	210.00M	264.00M	174.00M	469.00M	1.01B	503.00M	809.00M	672.00M	4.18B	4.47B	3.25B	3.02B	3.12B	3.51B	4.03B	4.24B	4.64B	5.10B	5.96B	7.36B	5.49B	10.58B	16.19B	16.26B	15.10B	14.90B	18.30B	18.25B	18.78B	16.63B	18.79B	17.09B	26.06B	30.51B	27.15B	24.17B	20.99B	18.02B	16.99B	17.72B
Net Debt	187.00M	224.00M	-401.00M	203.00M	977.00M	479.00M	746.00M	617.00M	4.10B	4.24B	2.98B	2.81B	2.88B	3.29B	2.75B	3.52B	3.59B	4.14B	3.49B	3.16B	3.48B	7.20B	10.56B	9.71B	9.04B	9.19B	14.12B	12.71B	14.45B	10.80B	13.89B	13.26B	22.19B	26.00B	21.06B	20.10B	17.46B	15.27B	13.29B	14.57B

Cash Flow

Currency: GBP	1991-06-30	1991-12-31	1992-06-30	1992-12-31	1993-06-30	1993-12-31	1994-06-30	1994-12-31	1995-06-30	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: GBP	1991-06-30	1991-12-31	1992-06-30	1992-12-31	1993-06-30	1993-12-31	1994-06-30	1994-12-31	1995-06-30	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	615.00M	657.00M	657.00M	927.00M	927.00M	1.05B	1.05B	2.45B	2.45B	1.25B	849.00M	615.00M	410.00M	510.00M	1.85B	4.61B	3.06B	4.85B	4.77B	5.59B	3.96B	5.79B	7.31B	7.84B	6.80B	6.25B	4.38B	7.22B	5.18B	2.57B	6.50B	6.92B	8.42B	8.02B	8.44B	7.95B	7.40B	6.77B	6.55B	7.30B
Investing Cash Flow	-851.00M	-372.00M	-372.00M	-858.00M	-858.00M	-1.36B	-1.36B	-4.74B	-4.74B	-4.79B	-104.00M	-657.00M	-830.00M	-896.00M	-484.00M	-2.44B	-1.12B	-954.00M	-1.10B	-1.12B	-1.59B	-3.06B	-2.07B	-4.01B	-1.87B	-112.00M	-2.63B	524.00M	-1.08B	6.04B	-1.27B	-1.44B	-1.55B	-5.35B	2.16B	-1.78B	-8.77B	-1.59B	-1.23B	-5.85B
Financing Cash Flow	473.00M	-466.00M	-466.00M	96.00M	96.00M	39.00M	39.00M	2.18B	2.18B	3.66B	-658.00M	-59.00M	339.00M	350.00M	-546.00M	-2.78B	-2.15B	-872.00M	-3.06B	-3.08B	-4.32B	-1.32B	-4.09B	-2.77B	-5.57B	-6.23B	-3.35B	-6.27B	-5.38B	-7.10B	-6.39B	-6.38B	-6.39B	-1.84B	-10.13B	-7.59B	823.00M	-5.64B	-4.73B	-1.63B
Capital Expenditure	606.00M	594.00M	594.00M	608.00M	608.00M	575.00M	575.00M	485.59M	485.59M	684.00M	401.00M	415.00M	475.00M	597.00M	1.10B	1.12B	1.23B	1.06B	255.00M	1.18B	1.59B	2.14B	2.07B	1.87B	1.64B	1.33B	1.52B	1.70B	1.75B	1.90B	2.35B	2.20B	1.80B	2.16B	2.24B	2.93B	2.26B	2.34B	2.98B	1.35B
Free Cash Flow	9.00M	63.00M	63.00M	319.00M	319.00M	478.00M	478.00M	1.96B	1.96B	568.00M	448.00M	200.00M	-65.00M	-87.00M	749.00M	3.49B	1.83B	3.79B	4.51B	4.41B	2.37B	3.65B	5.24B	5.97B	5.16B	4.92B	2.85B	5.52B	3.42B	668.00M	4.14B	4.72B	6.63B	5.86B	6.20B	5.02B	5.14B	4.42B	3.57B	5.96B
Dividends Paid	-	-	-	-	-	-	-	844.08M	844.08M	-	-	-	-	-	-	2.33B	2.33B	2.33B	2.48B	2.39B	2.60B	2.79B	3.01B	3.09B	3.21B	3.41B	3.81B	3.68B	3.84B	3.87B	4.85B	3.91B	3.93B	3.95B	3.98B	4.00B	3.47B	2.25B	2.44B	2.56B
FCF to OCF	1.46%	9.59%	9.59%	34.41%	34.41%	45.39%	45.39%	80.17%	80.17%	45.37%	52.77%	32.52%	-15.85%	-17.06%	40.44%	75.75%	59.90%	78.11%	94.65%	78.86%	59.83%	63.02%	71.70%	76.11%	75.95%	78.75%	65.26%	76.45%	66.17%	26.00%	63.80%	68.17%	78.67%	73.03%	73.47%	63.14%	69.50%	65.37%	54.50%	81.54%
Dividend Paid to FCF	-	-	-	-	-	-	-	42.99%	42.99%	-	-	-	-	-	-	66.75%	126.95%	61.56%	54.85%	54.24%	109.71%	76.48%	57.38%	51.81%	62.09%	69.20%	133.59%	66.65%	112.20%	579.94%	117.01%	82.82%	59.28%	67.49%	64.12%	79.65%	67.39%	50.79%	68.42%	43.06%

Earnings

Report Date	Jun 30, 2001	Feb 12, 2003	Apr 30, 2003	Jul 23, 2003	Jul 27, 2004	Oct 28, 2004	Feb 10, 2005	Apr 28, 2005	Jul 28, 2005	Oct 27, 2005	Feb 8, 2006	Apr 27, 2006	Jul 26, 2006	Oct 26, 2006	Feb 8, 2007	Apr 25, 2007	Jul 25, 2007	Oct 24, 2007	Feb 7, 2008	Apr 23, 2008	Jul 23, 2008	Oct 22, 2008	Feb 5, 2009	Apr 22, 2009	Jul 22, 2009	Oct 28, 2009	Feb 4, 2010	Apr 28, 2010	Jul 21, 2010	Oct 21, 2010	Feb 3, 2011	Apr 27, 2011	Jul 26, 2011	Oct 26, 2011	Feb 7, 2012	Apr 25, 2012	Jul 25, 2012	Oct 31, 2012	Feb 6, 2013	Apr 24, 2013	Jul 24, 2013	Oct 23, 2013	Feb 5, 2014	Apr 30, 2014	Jul 23, 2014	Oct 22, 2014	Feb 4, 2015	May 6, 2015	Jul 29, 2015	Oct 28, 2015	Feb 3, 2016	Apr 27, 2016	Jul 27, 2016	Oct 26, 2016	Feb 8, 2017	Apr 26, 2017	Jul 26, 2017	Oct 25, 2017	Feb 7, 2018	Apr 25, 2018	Jul 25, 2018	Oct 31, 2018	Feb 6, 2019	May 1, 2019	Jul 24, 2019	Oct 30, 2019	Feb 5, 2020	Apr 29, 2020	Jul 29, 2020	Oct 28, 2020	Feb 3, 2021	Apr 28, 2021	Jul 28, 2021	Oct 27, 2021	Feb 9, 2022	Apr 27, 2022	Jul 27, 2022	Nov 2, 2022	Feb 1, 2023	Apr 26, 2023	Jul 26, 2023	Nov 1, 2023	Jan 31, 2024	May 1, 2024	Jul 31, 2024	Oct 30, 2024	Feb 5, 2025	Apr 30, 2025	Jul 30, 2025	Oct 29, 2025	Feb 3, 2026	Apr 28, 2026	Jul 28, 2026	Oct 28, 2026
EPS Estimate	-	-	-	-	0.24	2.28	0.22	0.23	0.24	0.24	0.23	0.29	0.30	0.28	-	0.32	0.27	0.30	-	0.30	0.31	0.30	-	0.35	0.37	0.37	0.40	0.37	0.35	0.34	-0.08	0.39	0.32	0.35	0.37	0.36	0.33	0.35	0.39	0.32	0.33	0.27	0.31	0.21	0.21	0.24	0.26	0.17	0.17	0.19	0.18	0.18	0.21	0.30	0.25	0.25	0.26	0.32	0.26	0.24	0.26	0.33	0.28	0.25	0.25	0.33	0.25	0.31	0.25	0.38	0.29	0.27	0.25	0.36	0.31	0.38	0.29	0.40	0.22	0.33	0.35	0.46	0.29	0.36	0.38	0.43	0.19	0.40	0.42	0.46	0.25	0.47	0.47	0.53
EPS Actual	0.21	0.20	0.26	0.29	0.25	0.23	0.21	0.26	0.25	0.26	0.25	0.33	0.29	0.30	0.26	0.33	0.30	0.29	0.24	0.30	0.30	0.25	0.24	0.28	0.35	0.33	0.40	0.33	-0.07	0.31	-0.17	0.37	0.27	0.34	0.31	0.33	0.31	0.28	0.22	0.25	0.27	0.29	0.30	0.21	0.19	0.28	0.21	0.17	0.17	0.23	0.18	0.20	0.24	0.32	0.26	0.25	0.27	0.33	0.27	0.25	0.28	0.35	0.31	0.30	0.30	0.39	0.25	0.37	0.24	0.45	0.29	0.29	0.35	0.46	0.32	0.41	0.35	0.47	0.26	0.37	0.39	0.50	0.29	0.43	0.43	0.50	0.23	0.45	0.47	0.55	0.26	0.47	0.51	-
Surprise	-	-	-	-	4.71%	-89.91%	-4.55%	14.04%	5.42%	10.04%	6.78%	13.21%	-4.37%	8.75%	-	4.44%	9.70%	-2.03%	-	0.97%	-1.65%	-16.67%	-	-20.71%	-5.08%	-11.70%	-0.42%	-11.65%	-121.17%	-7.62%	-110.13%	-4.90%	-15.63%	-2.71%	-15.86%	-8.64%	-4.91%	-19.40%	-44.49%	-22.56%	-19.52%	6.50%	-2.82%	1.35%	-11.01%	16.54%	-17.12%	-0.35%	3.78%	19.48%	1.12%	10.43%	16.67%	8.18%	4.32%	0.94%	3.70%	1.75%	4.70%	1.44%	7.79%	6.99%	13.33%	18.78%	21.51%	15.81%	-1.74%	21.71%	-5.47%	16.49%	-0.21%	6.83%	39.90%	26.17%	4.40%	7.77%	19.97%	17.90%	17.01%	11.88%	10.73%	8.71%	0.94%	18.34%	14.60%	16.28%	21.05%	12.50%	11.90%	19.57%	0.04%	-0.15%	8.51%	-
Timing	-	-	-	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	After-hours

Key Statistics & Ratios

Market Cap71.31B

Enterprise Value90.70B

Trailing P/E15.08

Forward P/E9.72

PEG Ratio6.08

Price / Sales2.15

Price / Book4.28

EPS1.18

Book Value4.40

Revenue (TTM)33.20B

Gross Profit (TTM)24.40B

EBITDA10.82B

Profit Margin14.52%

Operating Margin30.94%

Return on Equity33.38%

Return on Assets10.01%

Shares Outstanding4.01B

Shares Float3.88B

Beta0.29

Dividend Yield3.82%

Dividend Rate0.68

Payout Ratio38.20%

Dividends

20264×

0.17Nov 12, 20260.17Aug 13, 20260.17May 14, 20260.18Feb 19, 2026

20254×

0.16Nov 13, 20250.16Aug 14, 20250.16May 15, 20250.16Feb 20, 2025

20244×

0.15Nov 14, 20240.15Aug 15, 20240.15May 16, 20240.16Feb 22, 2024

20234×

0.14Nov 16, 20230.14Aug 17, 20230.14May 18, 20230.14Feb 23, 2023

20224×

0.14Nov 17, 20220.16Aug 18, 20220.14May 19, 20220.23Feb 24, 2022

20214×

0.19Nov 18, 20210.19Aug 19, 20210.19May 20, 20210.23Feb 18, 2021

Stock Splits

Jul 19, 20224:5
Aug 12, 19961030:1013
Oct 28, 19912:1